Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist at Mayo Clinic, suggests that medical providers can reduce patient ...

Indian biopharmaceutical firm Biocon is likely to list its key biosimilars business by March 2026 and aims for double-digit share in its core U.S. market for its new launches, a top executive told ...

The global biosimilars market size was valued at USD 28.70 billion in 2024 and is projected to reach from USD 33.16 billion ...

As Sandoz gears up to launch one of the most anticipated biosimilars of the year, the company could face near-term ...